Welcome to Medications.com

Adderall XR News

UK Stocks Decline, Paced by Standard Life, RBS, Barclays - Bloomberg

Vyvanse is a successor to Adderall XR for attention deficit hyperactivity disorder. CRH Plc (CRH ID) fell 15 cents, or 0.8 percent, to 25.93 euros. ...

http://www.bloomberg.com/apps/new... | Posted: Wed Jan 30 06:08:52 -0500 2008

Fears over debt levels hit RBS and Barclays - Times Online

The broker said that 52 per cent of high prescribers saw no difference between Vyvanse and Shire’s older drug Adderall XR, whose patent is due to expire ...

http://business.timesonline.co.uk... | Posted: Wed Jan 30 19:02:06 -0500 2008

ADRs in Focus: Shire Rebounds - Houston Chronicle

"Vyvanse is not a simple switch from Adderall XR but captures competitors' market share, which should reduce the impact of Adderall (going generic) in April ...

http://www.chron.com/disp/story.m... | Posted: Thu Jan 31 15:50:41 -0500 2008

UK Stocks Fall, Led by Royal Bank, Barclays, Standard Life - Bloomberg

Vyvanse is a successor to Adderall XR for attention deficit hyperactivity disorder. Thomas Cook Group Plc (TCG LN), Europe's second-biggest tour operator, ...

http://www.bloomberg.com/apps/new... | Posted: Wed Jan 30 12:38:32 -0500 2008

ADRs in Focus: Shire Falls on Downgrade - Forbes

Dani Saurymper downgraded the stock to "Neutral" from "Buy," and said that doctors do not find Vyvanse to be superior to Adderall XR, Shire (nasdaq: SHPGY ...

http://www.forbes.com/feeds/ap/20... | Posted: Wed Jan 30 16:47:29 -0500 2008

More carnage for Shire - Guardian Unlimited

"This not only entails converting patients from Adderall XR but also the more significant patient population currently using alternative therapies. ...

http://blogs.guardian.co.uk/marke... | Posted: Wed Jan 30 08:15:45 -0500 2008

Shire hit by fears over hyperactivity drug - Times Online

Vyvanse is designed to replace the blockbuster Adderall XR, whose patent expires next year. Meanwhile, with little economic or earnings announcements to ...

http://www.timesonline.co.uk/tol/... | Posted: Mon Jan 28 19:06:28 -0500 2008

FTSE 100 movers: Copper rally lifts Antofagasta - ShareCast

Vyvanse is designed to replace the blockbuster Adderall XR, whose patent expires next year. BAE Systems slipped on a report that two of its flagship ...

http://www.sharecast.com/cgi-bin/... | Posted: Tue Jan 29 07:51:15 -0500 2008

Shire ADRs Fall to Annual Low Following Downgrade - CanadianBusiness.com

In a client note, Cacciatore said about 19 percent of Shire's Adderall XR users have switched to Vyvanse. He thinks that number will rise to about 40 ...

http://www.canadianbusiness.com/i... | Posted: Mon Jan 28 16:51:48 -0500 2008

UK Stocks Fall, Led by Royal Bank, Barclays, Standard Life - Bloomberg

Vyvanse is a successor to Adderall XR for attention deficit hyperactivity disorder. Thomas Cook Group Plc (TCG LN), Europe's second-biggest tour operator, ...

Posted: Wed Jan 30 12:38:32 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea